Ludwig Institute for Cancer Research

Ludwig Institute for Cancer Research

I am persuaded that eventual mastery of cancer will only come from intense and unremitting scientific exploration over many decades - Daniel K. Ludwig. December 17, 1974.

The Ludwig Institute for Cancer Research Ltd (LICR)is a global non profit committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.

Read More >

Partnerships

Human Cancer Genome Project

In 1999, LICR and FAPESP (The State of São Paulo Research Foundation) initiated the multi-million dollar HCGP to identify genes expressed in cancer, by comparing expressed sequence tags (ESTs) from tumor samples and normal tissues. In 2003, LICR and the U.S. National Cancer Institute combined their respective data sets to create the largest, publicly-available EST database, the Cancer Genome Anatomy Project (CGAP). These data enabled the identification of genes in the newly-completed sequencing of the human genome. More »